Interestingly, while most of previous studies have emphasized the crucial role of CD4+ T cells in immune status (Freiwald et al., 2020; Wik and Skålhegg, 2022), our study revealed no significant difference in CD4+ T cell counts between survival and deceased patients with p-ARDS. This evidence concerns the gene CD4 and acute respiratory distress syndrome.